AngioDynamics
- Market cap
- 596.75M
- P/E (TTM)i
- -16.13
- P/Bi
- 3.49
- EPSi
- -0.88
- Div yieldi
- 0.00%
- 52W posi
- 70%
Anonymous reader poll. Unscientific, not investment advice.
About AngioDynamics
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The firm offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. It operates through the Med Tech and Med Device segments. The Med Tech segment consists of technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment focuses on core, venous, ports, and other oncology products. The company was founded by Howard S. Stern and Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.
- Founded
- 1988
- CEO
- Mr. James C. Clemmer
- Employees
- 632
- Headquarters
- Latham, New York, United States of America
- Fiscal year end
- 05-31
- Website
- angiodynamics.com
Company profile
- Exchange
- US
- Symbol
- ANGO
- Market-cap rank
- #3631
- Market cap
- 596.75M
- Float cap
- 461.32M
- Shares out
- 42.05M
- Float shares
- 32.51M
Sectors & themes
Quote time 2026-10-08 09:19:27 · For reference only, not investment advice and not tailored to your situation.